Predicting benefit from revascularization in patients with ischemic heart failure: Imaging of myocardial ischemia and viability

Circulation

Volumn 123, Issue 4, 2011, Pages 444-450

  Buckley, Orla ^a,c   Di Carli, Marcelo ^b  

^a Department of Noninvasive Cardiovascular Imaging ^*  (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

cardiomyopathy; magnetic resonance imaging; myocardial ischemia; positron emission tomography; revascularization; viability

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MOVEMENT; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MYOCARDIAL PERFUSION IMAGING; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79751479595     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.903369     Document Type: Article

References (26)

1. Beanlands RS, Ruddy TD, deKemp RA, Iwanochko RM, Coates G, Freeman M, Nahmias C, Hendry P, Burns RJ, Lamy A, Mickleborough L, Kostuk W, Fallen E, Nichol G. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol. 2002;40:1735-1743. (Pubitemid 35341950)
2. Di Carli MF, Hachamovitch R, Berman DS. The art and science of predicting postrevascularization improvement in left ventricular (LV) function in patients with severely depressed LV function. J Am Coll Cardiol. 2002;40:1744-1747. (Pubitemid 35341951)
3. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure, III: the role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994;272:1528-1534. (Pubitemid 24340796)
4. Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007; 115:1464-1480. (Pubitemid 46648384)
5. Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJ. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298-1304. (Pubitemid 29440122)
6. Cleland JG, Pennel D, Ray S, Murray G, MacFarlane P, Cowley A, Coats A, Lahiri A; The CHRISTMAS Study Steering Committee and Investigators. The carvedilol hibernation reversible ischaemia trial: marker of success (CHRISTMAS). Eur J Heart Fail. 1999;1:191-196. (Pubitemid 30186711)
7. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-1158. (Pubitemid 34267418)
8. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 1993;87:1-20. (Pubitemid 23019329)
9. Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, Shea NL, Oates E, Konstam MA. Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation. 1994;89:2552-2561.
10. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663-670.
11. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrastenhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-379. (Pubitemid 36164969)
12. Mahnken AH, Koos R, Katoh M, Wildberger JE, Spuentrup E, Buecker A, Gunther RW, Kuhl HP. Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol. 2005; 45:2042-2047. (Pubitemid 40814129)
13. Lardo AC, Cordeiro MA, Silva C, Amado LC, George RT, Saliaris AP, Schuleri KH, Fernandes VR, Zviman M, Nazarian S, Halperin HR, Wu KC, Hare JM, Lima JA. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation. 2006;113: 394-404. (Pubitemid 43803201)
14. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997;30:1451-1460. (Pubitemid 27486461)
15. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007; 32:375-410. (Pubitemid 46881171)
16. Kim RJ, Hillenbrand HB, Judd RM. Evaluation of myocardial viability by MRI. Herz. 2000;25:417-430. (Pubitemid 30470081)
17. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease: a functional and morphological approach to the detection of residual myocardial viability. Circulation. 1995;91:1006-1015.
18. Kuhl HP, Beek AM, Van der Weerdt AP, Hofman MB, Visser CA, Lammertsma AA, Heussen N, Visser FC, Van Rossum AC. Myocardial viability in chronic ischemic heart disease: comparison of contrastenhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2003;41: 1341-1348. (Pubitemid 36442708)
19. Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, Maddahi J. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 1995;92:3436-3444.
20. Louie HW, Laks H, Milgalter E, Drinkwater DC Jr, Hamilton MA, Brunken RC, Stevenson LW. Ischemic cardiomyopathy: criteria for coronary revascularization and cardiac transplantation. Circulation. 1991; 84(suppl):III-290-III-295.
21. Rahimtoola SH, Dilsizian V, Kramer CM, Marwick TH, Vanoverschelde JL. Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. J Am Coll Cardiol Cardiovasc Imaging. 2008;1:536-555. (Pubitemid 352005803)
22. Yamaguchi A, Ino T, Adachi H, Mizuhara A, Murata S, Kamio H. Left ventricular endsystolic volume index in patients with ischemic cardiomyopathy predicts postoperative ventricular function. Ann Thorac Surg. 1995; 60:1059-1062.
23. Yamaguchi A, Ino T, Adachi H, Murata S, Kamio H, Okada M, Tsuboi J. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg. 1998;65:434-438. (Pubitemid 28083340)
24. Jones RH, Velasquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL, STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360:1705-1717.
25. Elsasser A, Schlepper M, Klovekorn WP, Cai WJ, Zimmermann R, Muller KD, Strasser R, Kostin S, Gagel C, Munkel B, Schaper W, Schaper J. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 1997;96:2920-2931. (Pubitemid 27500091)
26. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation. 1998;98(suppl):II-51-II-56. (Pubitemid 28512165)